Please assess the completion status of the following clinical trial:

Trial Title: Behavioral Therapy Development for Methamphetamine Abuse

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the University of California, Los Angeles (UCLA) Center for Clinical AIDS Research and Education (CARE) clinic, aged 18-65~2. Willing to give informed consent and comply with study procedures~3. Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications~4. Diagnosed with current methamphetamine abuse as determined by Mini-International Neuropsychiatric Interview (MINI)~5. Interested in seeking treatment for methamphetamine abuse and in participating in this research project.~Exclusion Criteria:~1. Unwilling to give, or withdrawal of, informed consent~2. Inability to understand nature of study~3. A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision \[DSM-IV-TR\] criteria for current bipolar disorder or a psychotic disorder)~4. Current suicidal ideation or suicide attempt within the past 3 months~5. Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.~6. Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).